-lapachone, a quinone compound obtained from the bark of the lapacho tree (Tabebuia avellanedae), was reported to have anti-inflammatory and anti-cancer activities. In this study, we investigated novel functions of -lapachone in terms of anti-metastasis and antiinvasion abilities using human hepatocarcinoma cell lines, HepG2 and Hep3B. -lapachone dose-dependently inhibited cell viability and migration of both HepG2 and Hep3B cells, as determined by methylthiazoletetrazolium (MTT) assay and wound healing assay. RT-PCR and Western blot data revealed that -lapachone dramatically increased the levels of protein, as well as mRNA expression of early growth response gene-1 (Egr-1) and throbospondin-1 (TSP-1) at an early point in time, and then decreased in a time-dependent manner. In addition, down-regulation of Snail and up-regulation of Ecadherin expression were observed in -lapachonetreated HepG2 and Hep3B cells, and this the associated with decreased invasive ability as measured by matrigel invasion assay. Taken together, our results strongly suggest that -lapachone may be expected to inhibit the progression and metastasis of hepatoma cells, at least in part by inhibiting the invasive ability of the cells via upregulation of the expression of the Egr-1, TSP-1, and Ecadherin.
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Early growth response gene-1 (Egr-1) is a Cys2-His2-typed zinc-finger transcription factor that has been implicated in the regulation of a number of genes involved in inflammation, differentiation, growth, and development.
1) It also regulates the expression of a diverse array of genes involved in tumor metastasis, including throbospondin-1 (TSP-1), plasminogen activator inhibitor-1 (PAI-1), and transforming growth factor-1 (TGF-1).
2,3) TSP-1 is a potent inhibitor of neovascularization that limits tumor growth and stimulates apoptosis and growth inhibition in neovascular endothelial cells. [4] [5] [6] Expression of TSP-1 is decreased in tumor cells that contain mutations in various oncogenes and tumor suppressor genes, 7) and it suppresses the growth of responsive tumor cells. 8) High TSP-1 expression is also inversely correlated with invasiveness and lymph node metastasis. 8, 9) Invasion by cancer cells of the surrounding tissue correlates with cellular malignancy and metastasis. Many factors, such as cell-cell adhesion molecules, matrix proteinases, and cytokines, are associated with local invasion and scattering of the cells. 10) Snail is one such gene; it repress E-cadherin promoter activity by binding to the E-box sequences.
11) Snail was originally identified as a transcription factor and was implicated in the epithelial mesenchymal transition (EMT) during embryonic development.
12) Increased expression of Snail in invasive cancer cells accompanied by a loss of E-cadherin expression have been reported in many types of human cancers, including melanoma, hepatocarcinoma, and squamous cell carcinoma. [11] [12] [13] [14] It has recently been shown that down-regulation of Ecadherin expression is mediated by the zinc-finger transcription factor Snail. 15, 16) E-cadherin is a cell-cell adhesion molecule that is especially expressed on the membranes of epithelial cells, and decreased expression of it has been reported in invasion and metastasis of cancers. 17, 18) This down-regulation of E-cadherin expression has been explained by the hypermethylation of its promoter region in some cancer cells. 19) -lapachone (3,4-dihydro-2,2-dimenthyl-2H-napthol- [1, 2] pyran-5,6-dione) is a naturally occurring quinine obtained from the bark of the lapacho tree (Tabebuia avellanedae), which is native to South America. 20) This compound exhibits a number of pharmacological actions, including anti-bacterial, anti-fungal, anti-trypanocidal, and cytotoxic activities, 21, 22) that are linked to the formation of reactive oxygen species. 23, 24) -lapachone has been shown to induce cell cycle arrest and apoptosis in a variety of cancer cell lines, [25] [26] [27] [28] [29] [30] [31] [32] [33] but the molecular mechanisms of its anti-metastasis and anti-invasive activities are not known. Therefore, we tested the hypothesis that -lapachone modulates the invasion of cancer cells in vitro, and that this occurs via regulation of the expressions of genes such as Egr-1, TSP-1, Snail, and E-cadherin. Accordingly, here, we confirmed the hypothesis that cell motility and invasion are inhibited by -lapachone, and that this occurs via regulation of protein and mRNA expression in human hepatocellular carcinoma cells.
Materials and Methods
Cell culture and -lapachone. Human hepatoma cell lines, HepG2 and Hep3B, were obtained from the American Type Culture Collection (Rockville, MD) and cultured in DMEM (Gibco BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin in an incubator maintained at 37 C with 5% CO 2 . -lapachone was purchased from Biomol (Plymouth Meeting, PA) dissolved in ice-cold absolute ethanol as a stock solution at a concentration of 10 mM, and stored in aliquots at À20 C.
MTT assay. The cell viability was analyzed by a methylthiazoletetrazolium (MTT) assay, which measures the metabolic activity of mitochondria. Cells were seeded at 2 Â 10 6 cells in 1 ml of culture medium in each well of a 6-well plate. After culturing for 24 h, the cells were treated with -lapachone for 24 h, and then were incubated with 0.5 mg/ml MTT (Chemicon, Temecula, CA) in PBS for 4 h to change MTT to formazan at 37 C in a 5% CO 2 incubator. Dimethyl sulfoxide (DMSO, Sigma Chemical, St. Louis, MO) was then added to solubilize the formed, colored formazan product. The optical density of the solution at 540 nm (absorbed by formazan dye) was determined using an ELISA plate reader (Molecular Devices, Sunnyvale, CA) with a reference wavelength of 630 nm.
RNA extraction and reverse transcription-polymerase chain reaction (RT-PCR). Total RNA was prepared using Trizol reagent (Gibco BRL) according to the recommendations of the manufacturer, and was then used for RT-PCR with one step RT-PCR premix (Introbiotechnology, Seoul, Republic of Korea) according to the instructions of the manufacturer. PCR was carried out in a Mastercycler (Eppendorf, Hamburg, Germany) with the primers indicated in Table 1 . Conditions for PCR were 1 Â (94 C for 3 min); 35 Â (94 C for 45 s; 58 C for 45 s; and 72 C for 1 min), and 1 Â (72 C for 10 min). As a control for sample loading and normalization between samples, PCR amplification of the housekeeping gene, glyceraldehydes-3-phosphate dehyderogenase (GAPDH), was included for each sample at each run. Amplification products obtained by PCR were electrophoretically separated on 1% agarose gel and visualized by ethidium bromide (EtBr, Sigma) staining.
Western blotting.
Immunoblots were prepared to analyze the protein levels of Egr-1 (Santa Cruz Biotechnology, Santa Cruz, CA), TSP-1 (NeoMarkers, Labvison, Fremont, CA), snail (Abgent, San Diego, CA), E-cadherin (Santa Cruz), -catenin (Santa Cruz), and -actin (Sigma). After treatment with -lapachone for the indicated amounts of time, the cells were Aliquots containing 40 mg of total cell proteins were resolved on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred onto PVDF membranes (Sigma). Membranes were blocked in 5% nonfat milk powder (w/v) in PBS containing 0.01% Tween-20 for 1 h at room temperature and then probed using the above-mentioned primary antibodies. After incubation overnight at 4 C, membranes were washed in PBST and incubated with the appropriate peroxidaseconjugated secondary antibody (Amersham, Arlington Heights, IL). Specific complexes were revealed by chemiluminescence according to enhanced chemiluminescence Western blotting detection reagent (Pierce, Rockford, IL).
Wound-healing experiment. To test the effect oflapachone on the motility of hepatocarcinoma cells, a wound-healing experiment was performed. This assay measures the rate of motility of cells in filling in an empty area of the tissue culture plate created by scratching a confluent monolayer of cells. Cells were grown to confluency on 30-mm cell culture dishes coated with rat tail collagen (20 mg/ml), and then treated with vehicle or -lapachone for 3 h. A scratch was made through the cell layer using a pipette tip. After washing with PBS, serum-free media (to prevent cell proliferation) containing either vehicle (DMSO) or -lapachone (3.5 mM) was added. Photographs of the wounded area were taken immediately after the scratch was made, and 12 and 24 h later to monitor cell movement into the wounded area.
Matrigel invasion assay. In order to measure the effect of -lapachone on cell invasiveness by Boyden chamber invasion assay, cells were exposed to 3.5 mM of -lapachone for 6 h. This treatment was not cytotoxic, as shown by MTT assay. Treated cells (50,000) were plated onto the apical side of the matrigel-coated filters in serum-free medium containing either -lapachone (3.5 mM) or DMSO. Medium containing 20% FBS was placed in the basolateral chamber to act as a chemoattractant. After 36 h, cells on the apical side were wiped off with a cotton swab, cells on the bottom of the filter were stained with hematoxylin and counted (three fields of each triplicate filter) using an inverted microscope.
Results
Inhibition of cell growth and cell motility bylapachone in HepG2 and Hep3B cells Initially, we determined the cytotoxic effect oflapachone on the growth of hepatocarcinoma cells. As shown in Fig. 1 , -lapachone had strong inhibitory effects on both HepG2 and Hep3B cell proliferation in a dose-dependent manner. To determine whether -lapachone inhibits the cell motility of HepG2 and Hep3B cells, the wound healing experiment was performed. The results, as shown in Fig. 2 , demonstrated that 3.5 mM -lapachone delayed the cell motility of HepG2 and Hep3B cell lines in a time-dependent manner as compared to the of control cells. No significant differences were observed in the cell mobility of the two cell lines.
Induction of Egr-1 and TSP-1 expression bylapachone in HepG2 and Hep3B cells
We determined whether -lapachone would induce the expression of Egr-1 in HepG2 and Hep3B cells. The cells were incubated with 3.5 mM -lapachone for the indicated amounts of time, and the levels of Egr-1 mRNA and protein were measured by RT-PCR and Western immunoblotting (Fig. 3) . Egr-1 mRNA in HepG2 was expressed later than that of Hep3B, and was detected at a time point as early as 30 min in Hep3B. The levels of Egr-1 protein induction in these cells due to -lapachone were maximal at about 1 to 3 h, and then gradually decreased to the basal level. Egr-1 is a transcription factor known to regulate the expression of a variety of genes, some of which have possible antiinvasion activities. One possible candidate gene that has been proposed to mediate the invasion is TSP-1. TSP-1 is reported to inhibit invasion as well as angiogenesis. Hence, we tested TSP-1 expression in two hepatoma and Hep3B Cells. Cells were seeded into 6-well plates at 2 Â 10 6 cells in 1 ml culture medium. After culturing for 24 h, these cells were treated with -lapachone at varying concentrations for 24 h. Thereafter, cell survival and toxicity were determined by an MTT test according to dose-dependent activity.
cell lines by -lapachone treatment, as shown in Fig. 3A and B. Levels of TSP-1 mRNA in two cell lines were induced about 30 min later than Egr-1. TSP-1 protein expression in HepG2 was maximal at 6 h, but that of Hep3B was induced at 30 min to 1 h, and then decreased to the basal level. These findings suggest thatlapachone, which induced Egr-1 expression, results in the expression of TSP-1 during tumor cell invasion, and also indicate that TSP-1 might act as an anti-invasive mediator in hepatoma cell lines.
Changes in Snail and E-cadherin expression due tolapachone in HepG2 and Hep3B
The levels of Snail and E-cadherin expression were measured by RT-PCR in HepG2 and Hep3B; they are shown in Fig. 4A . These results indicate that expression levels of Snail in HepG2 and in Hep3B cells decreased for about 3 h after treatment with -lapachone. There were no significant differences in Snail expression between two cell lines. Those of E-cadherin increased significantly at about 2 to 3 h, with down-regulation of Snail. We then used immunoblotting to confirm that E-cadherin protein expression and Snail protein expression. The results for Snail in two cell lines decreased significantly after 2 to 3 h. Conversely, those of Ecadherin increased dramatically at 3 h in HepG2 cells, and that of Hep3B cells was also seen at 2 h (Fig. 4B) . These results indicate that down-regulation of Snail with -lapachone treatment was correlated with up-regulation of E-cadherin expression. Cells were grown to confluency on 35-mm cell culture dishes coated with rat tail collagen (20 mg/ml), and then treated with vehicle or 3.5 mM -lapachone for 24 h. A scratch was made through the cell layer using a pipette tip. After washing with PBS, serum-free media (to prevent cell proliferation) containing either vehicle (DMSO) or 3.5 mM -lapachone was added. Photographs of the wounded area were taken immediately after the scratch was made and 12 and 24 h later to monitor cell movement into the wounded area. A, After treatment with -lapachone for the indicated times, total RNAs were isolated and RT-PCR analyses were performed using the Egr-1 and TSP-1 primers. GAPDH was used as a housekeeping control gene. B, Total protein (40 mg) was fractionated on SDS-polyacrylamide gels and transferred onto PVDF membranes. The membranes were probed with anti-Egr-1 and anti-TSP-1 antibodies. Proteins were visualized by the chemiluminescence detection system. Actin was used as a loading control.
Inhibition of cell invasion by -lapachone in hepatoma cell line HepG2 and Hep3B
To measure the effect of -lapachone on hepatoma cell invasiveness by Boyden chamber invasion assay, cells were treated with either 3.5 mM -lapachone or DMSO, cells were then placed on the apical chamber of a transwell, and a chemoattractant was placed in the basolateral chamber. Cells ''invade'' through a layer of matrigel on the membrane and migrate through an 8 mM pore to reach the basolateral side. When the number of cells reaching the basolateral side was compared, it was seen that -lapachone strongly inhibited the invasiveness of HepG2 and Hep3B cells (Fig. 5) . Hence, we conclude that -lapachone significantly inhibited two determinants of metastatic potential, motility and invasiveness.
Discussion
Many researchers have given consideration tolapachone as a candidate anti-cancer agent. Recent investigations by our group and others have indicated that -lapachone induced G1 arrest of the cell cycle and induced apoptosis in various tumor cells, including human lung carcinoma A549, human leukemic HL-60, breast carcinoma MCF-7, and prostate carcinoma PC3 cells. [31] [32] [33] The objective of the present study was to determine whether -lapachone has potent anti-metastasis and anti-invasion activities in hepatoma cell lines, HepG2 and Hep3B, through Egr-1-meditated expression of anti-invasion genes, up-regulated expression of TSP-1 and E-cadherin, and down-regulation of Snail.
In this study, we found that -lapachone had a strong inhibitory effect on HepG2 and Hep3B cell proliferation A, Cells were grown under the same conditions as described in Fig. 2 , total RNAs were isolated, and RT-PCR analyses were performed using the Snail and E-cadherin primers. GAPDH was used as a housekeeping control gene. B, Total protein (40 mg) was fractionated on SDSpolyacrylamide gels and transferred onto PVDF membranes. The membranes were probed with anti-E-cadherin antibody. Proteins were visualized by the chemiluminescence detection system. Actin was used as a loading control. Cells were grown in a Biocoat Matrigel invasion chamber and treated with DMSO or 3.5 mM -lapachone. After 24 h, they were wiped off the apical sides of the transwells (inside), fixed with methanol, stained with hematoxylin, and counted under a microscope. The data indicate the mean AE S.D. of three independent experiments. The data were evaluated for statistic significance by a t-test. The means noted with an asterisk were statistically different from the control. A p-value < 0:05 was considered significant. in a dose-dependent manner. We also checked the state of apoptosis in both cell lines by DAPI staining and flow cytometry. The results indicate that following -lapachone treatment, HepG2 and Hep3B cells accomplish apoptosis and that there is good correspondence between the extent of apoptosis and growth inhibition (results not shown). We then confirmed that -lapachone inhibited the cell motility of HepG2 and Hep3B by the woundhealing experiment. The results demonstrate thatlapachone inhibited the cell motility of HepG2 and Hep3B cells in a time-dependent manner as compared to the control cells. There were, however, no significant differences in as brtween cell motility observed in the two cell lines.
Metastasis is the ultimate cause of death in any type of cancer, and yet this aspect of cancer biology remains poorly understood because of the complexity of the metastatic process. Metastasis is negatively controlled by the tumor metastasis suppressor genes, but to date only a few genes have been identified. As a first step towards elucidating the effect of -lapachone on the mechanism by which Egr-1 inhibits metastatic and invasive activity in cancer cells, we have found that Egr-1 serves as a metastasis suppression gene, although information regarding the mechanism by which Egr-1 suppresses metastasis is still lacking.
Recent studies indicate that TSP-1, an anti-angiogenic and anti-invasion protein, can be up-regulated by over expression of Egr-1. 34, 35) Additionally, a study by Miyoshi et al. also suggests that Snail, a zinc-finger transcription factor, represses E-cadherin expression and induces matrix metalloproteinase expression, which causes vascular invasion and intrahepatic metastasis in primary hepatocellular carcinoma tumors. 36) Activation of E-cadherin gene expression resulted in growth retardation of tumor cell lines. Several immunohistochemical studies have also reported a strong correlation between loss of E-cadherin and the initiation and progression of tumors. [15] [16] [17] [18] [19] E-cadherin expression is often reduced or absent in many epithelial cancers, including gastric and breast cancer. 37, 38) Additionally, Grotegut et al. reported that Snail represses its target genes, among them E-cadherin and tight junction proteins, but also Egr-1, thus mediating a negative feedback loop. 39) Battle et al. and Barrallo-Gimeno and Nieto reported that Snail might regulate other genes required for the scattering process, in conjunction with E-cadherin down-regulation. In fact, Snail-mediated repression of a number of components of adherens, tight, and desmosomal junctions has been recently reported. 11, 40) Peiro et al. found that Snail binds to the Egr-1 promoter and represses its transcription and, recently, snail has been also shown to repress its own transcription. 41) Although further study is necessary, we cautiously suggest that Egr-1 affected expression of Snail, TSP-1, and also E-cadherin in hepatoma cells treated with -lapachone.
Our present results indicate that TSP-1 occurs downstream of the Egr-1 signal pathway, and also suggest that Egr-1 expression was induced by -lapachone in two cell lines. These genes were found to show a positive correlation. To determine the effect of up-regulated Egr-1 expression by -lapachone in HepG2 and Hep3B cells, Snail and E-cadherin expression levels were analyzed.
Expression of E-cadherin was associated with downregulation of Snail; these findings are similar to those of other reports related to anti-tumorigenic gene expression. To confirm the inhibition of tumor cell invasion, HepG2 and Hep3B cells treated with -lapachone were subjected to a matrigel invasion assay. The results indicated that -lapachone significantly decreased the invasiveness of two hepatoma cell lines, HepG2 and Hep3B.
In conclusion, since Egr-1 is widely known as a tumor suppressor gene and a transcription factor in various epithelial cell types, we investigated the possible link between Egr-1, TSP-1, Snail, and E-cadherin expression. Although further studies are needed to validate these results, our present findings indicate thatlapachone potently suppresses cell metastasis and invasion of two hepatoma cell lines, HepG2 and Hep3B, by up-regulating Egr-1 and TSP-1, and also by downregulating Snail and activating E-cadherin expression. Accordingly, our studies are the first to show thatlapachone in hepatocyte carcinoma cells stimulates Egr-1, TSP-1, and E-cadherin expression, and thatlapachone appears to play a role in inhibiting metastasis and invasion of hepatoma cell lines.
